To evaluate the potential therapeutic targeting of ligand-dependent Notch signaling in CLL, we considered our functional results above showing that DLL4 promoted effective Notch activation in NOTCH1-mutated CLL cells. The gene discussed is DLL4; the disease is B-cell chronic lymphocytic leukemia.